The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Satisfaction in older patients by geriatric assessment using a novel tablet-based questionnaire system: A cluster-randomized, phase III trial of patients with non–small-cell lung cancer (ENSURE-GA study; NEJ041/CS-Lung001).
 
Sayo Soda
No Relationships to Disclose
 
Kie Mirokuji
No Relationships to Disclose
 
Ryota Saito
No Relationships to Disclose
 
Kei Takamura
No Relationships to Disclose
 
Ryo Morita
No Relationships to Disclose
 
Naoki Furuya
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Novartis; Pfizer; Taiho Pharmaceutical
 
Shoichi Kuyama
No Relationships to Disclose
 
Ayako Shiono
No Relationships to Disclose
 
Daisuke Arai
Honoraria - AstraZeneca; Chugai Pharma; MSD; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical
 
Shinobu Hosokawa
Speakers' Bureau - AstraZeneca Japan; Bristol Myers Squibb K.K.; Chugai Pharma; Ono Pharmaceutical
 
Ken Masubuchi
No Relationships to Disclose
 
Naoko Matsumoto
No Relationships to Disclose
 
Hajime Asahina
Honoraria - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Hakko Kirin; Lilly; Merck; MSD; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca
 
Haruka Kondo
No Relationships to Disclose
 
Ryoichi Honda
No Relationships to Disclose
 
Noboru Hattori
Honoraria - Lilly Japan; Taiho Pharmaceutical
Speakers' Bureau - AstraZeneca/Hong Kong; Boehringer Ingelheim
 
Akihito Yokoyama
No Relationships to Disclose
 
Kunihiko Kobayashi
Speakers' Bureau - AstraZeneca; Takeda
 
Takeshi Isobe
Speakers' Bureau - AstraZeneca/Hong Kong; Boehringer Ingelheim
 
Yukari Tsubata
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Kyowa Kirin International; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Ono Pharmaceutical (Inst)